Stock OPHTHALIX INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Ophthalix Inc Other OTC

Equities

US6837362010

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wize Pharma : to change name to Mawson Infrastructure Group Inc
AQ
MAWSON INFRASTRUCTURE GROUP INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
Insider Trends: Wize Pharma Insider 90-Day Buying Trend Added to with Purchase
MT
Insider Trends: Insider Buying Continued with Purchase of Wize Pharma Stock
MT
Insider Trends: Insider Purchase Adds to Wize Pharma Positive Trend
MT
WIZE PHARMA, INC. : Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
WIZE PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
AQ
Vertua Limited (NSX:VERA) Cosmos Investment Impact
AQ
WIZE PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
WIZE PHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
WIZE PHARMA, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
WIZE PHARMA, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Wize Pharma : Receives Bonus BioGroup Shares from Escrow and Additional Bonus BioGroup Shares Totaling $1.3 Million
PR
WIZE PHARMA, INC. : Material Modification to Rights of Security Holders (form 8-K)
AQ
WIZE PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Wize Pharma : and Cosmos Capital enter into Bid Implementation Agreement
PR
WIZE PHARMA, INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
WIZE PHARMA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
WIZE PHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Wize Pharma : Announces Positive Topline Results in Phase IV Study of LO2A for the Treatment of Dry Eye Syndrome in Patients with Sjögren's Syndrome
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WIZP Stock
  4. Stock
  5. News Ophthalix Inc